All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
21Nov18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Consolidation of Trading Lines
20Nov18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Block Admission Six Monthly Return/TVR
16Nov18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Webinar: non-viral cell engineering
14Nov18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Clinical and Commercial License Agreement
12Nov18 07:00 RNS MaxCyte, Inc. -1.02% Various Various MaxCyte Announces Research Agreement with Kite
09Nov18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Expansion of CRISPR Commercial License Agreement
31Oct18 16:25 RNS MaxCyte, Inc. -1.02% Various Various Result of AGM
10Oct18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Dosing Begins in First Clinical Trial of MCY-M11
08Oct18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Notice of AGM
24Sep18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Results for the Half Year ended 30 June 2018
10Sep18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Grant of Options
03Sep18 07:00 RNS MaxCyte, Inc. -1.02% Various Various Notice of Half Year Results
Date / Time Source Company % Chg
21Nov18 07:00 RNS MaxCyte, Inc. -1.02%
Consolidation of Trading Lines
20Nov18 07:00 RNS MaxCyte, Inc. -1.02%
Block Admission Six Monthly Return/TVR
16Nov18 07:00 RNS MaxCyte, Inc. -1.02%
Webinar: non-viral cell engineering
14Nov18 07:00 RNS MaxCyte, Inc. -1.02%
Clinical and Commercial License Agreement
12Nov18 07:00 RNS MaxCyte, Inc. -1.02%
MaxCyte Announces Research Agreement with Kite
09Nov18 07:00 RNS MaxCyte, Inc. -1.02%
Expansion of CRISPR Commercial License Agreement
31Oct18 16:25 RNS MaxCyte, Inc. -1.02%
Result of AGM
10Oct18 07:00 RNS MaxCyte, Inc. -1.02%
Dosing Begins in First Clinical Trial of MCY-M11
08Oct18 07:00 RNS MaxCyte, Inc. -1.02%
Notice of AGM
24Sep18 07:00 RNS MaxCyte, Inc. -1.02%
Results for the Half Year ended 30 June 2018
10Sep18 07:00 RNS MaxCyte, Inc. -1.02%
Grant of Options
03Sep18 07:00 RNS MaxCyte, Inc. -1.02%
Notice of Half Year Results
Date / Time Company % Chg
21Nov18 07:00 MXCR LSE,MXCT LSE -1.02%
Consolidation of Trading Lines
20Nov18 07:00 MXCR LSE,MXCT LSE -1.02%
Block Admission Six Monthly Return/TVR
16Nov18 07:00 MXCR LSE,MXCT LSE -1.02%
Webinar: non-viral cell engineering
14Nov18 07:00 MXCR LSE,MXCT LSE -1.02%
Clinical and Commercial License Agreement
12Nov18 07:00 MXCR LSE,MXCT LSE -1.02%
MaxCyte Announces Research Agreement with Kite
09Nov18 07:00 MXCR LSE,MXCT LSE -1.02%
Expansion of CRISPR Commercial License Agreement
31Oct18 16:25 MXCR LSE,MXCT LSE -1.02%
Result of AGM
10Oct18 07:00 MXCR LSE,MXCT LSE -1.02%
Dosing Begins in First Clinical Trial of MCY-M11
08Oct18 07:00 MXCR LSE,MXCT LSE -1.02%
Notice of AGM
24Sep18 07:00 MXCR LSE,MXCT LSE -1.02%
Results for the Half Year ended 30 June 2018
10Sep18 07:00 MXCR LSE,MXCT LSE -1.02%
Grant of Options
03Sep18 07:00 MXCR LSE,MXCT LSE -1.02%
Notice of Half Year Results